Novartis sets 2020 target for commercial readiness of cell therapy CMO
Novartis aims to have its Japanese cell therapy CMO commercially ready in the second half of 2020.
Archives for December 10, 2019
BASi completes PCRS takeover, continuing deal-driven expansion
BASi buys PCRS, adding surgical and medical device contract services to growing portfolio.
CSafe launches temperature-controlled packaging for cell therapies
CSafe expands its cold chain offering with a series of logistics services suitable for temperature-controlled shipping of biologics.